| P – Patients undergoing induction treatment for AML |
| I – Cytarabine or Ara-C or Arabinoside-C – 100 mg/m2/day |
| C – Cytarabine or Ara-C or Arabinoside-C – 200 mg/m2/day |
| O – Complete remission rate, overall survival, and disease-free survival |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.